GPS Wealth Strategies Group’s Cardlytics CDLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$345 Hold
30
﹤0.01% 570
2025
Q3
$729 Hold
30
﹤0.01% 1493
2025
Q2
$494 Hold
30
﹤0.01% 1479
2025
Q1
$546 Hold
30
﹤0.01% 1400
2024
Q4
$1.11K Hold
30
﹤0.01% 1285
2024
Q3
$960 Hold
30
﹤0.01% 1291
2024
Q2
$2.46K Hold
30
﹤0.01% 1181
2024
Q1
$4.35K Hold
30
﹤0.01% 1023
2023
Q4
$2.76K Hold
30
﹤0.01% 1081
2023
Q3
$4.95K Hold
30
﹤0.01% 973
2023
Q2
$1.9K Hold
30
﹤0.01% 1114
2023
Q1
$1.02K Buy
+30
New +$1.57K ﹤0.01% 1160

Other funds holding CDLX

GPS Wealth Strategies Group's CDLX Position: Q4 2025 in Review

GPS Wealth Strategies Group held its Cardlytics (CDLX) position steady in Q4 2025 at 30 shares worth $345. The position accounts for ﹤0.01% of the portfolio, ranked #570.

GPS Wealth Strategies Group first reported a position in CDLX in Q1 2023 and has held it in 12 quarters since. The position peaked at $4.95K in Q3 2023. 70 funds tracked by Wall St. Rank hold CDLX as of Q4 2025.

  • GPS Wealth Strategies Group held 30 shares of Cardlytics worth $345 as of Q4 2025.
  • GPS Wealth Strategies Group left its Cardlytics share count unchanged in Q4 2025.
  • Cardlytics made up ﹤0.01% of GPS Wealth Strategies Group's portfolio in Q4 2025, its #570 holding.
  • GPS Wealth Strategies Group first reported a position in Cardlytics in Q1 2023 and has held it in 12 quarters since.
  • GPS Wealth Strategies Group's Cardlytics position peaked at $4.95K in Q3 2023.
  • 70 funds tracked by Wall St. Rank held Cardlytics as of Q4 2025.

Based on GPS Wealth Strategies Group's 13F filing for Q4 2025, filed 6 Feb 2026.